COPD Trial, Recruiting (NCT06798077)

COPD Trial, Recruiting NCT06798077 Sponsor: China-Japan Friendship Hospital Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06798077 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 40 or older who have been diagnosed with chronic obstructive pulmonary disease (COPD), or people aged 18 or older who have been diagnosed with asthma or bronchiectasis.
People whose main reason for being admitted to hospital was a flare-up of COPD, asthma that was difficult to control, or a flare-up of bronchiectasis.

Who may not be able to join:

People who are unable to complete a breathing test (called spirometry) once their condition has settled.
People whose doctors expect them to survive less than one month.
People who choose not to sign the consent form agreeing to take part in the study.
People whose chest scans show certain types of abnormal findings, such as patches, solid areas, glassy-looking changes, or changes in the lung tissue, with or without fluid around the lungs.
People who have cystic fibrosis, interstitial lung disease, or other lung conditions that cause certain types of airway widening.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ting Yang, MD, China-Japan Friendship Hospital, National Center for Respiratory Medicine

Phone: +8615120079197

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06798077

Sponsor: China-Japan Friendship Hospital

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +8615120079197

More information: https://clinicaltrials.gov/study/NCT06798077

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 40 or older who have been diagnosed with chronic obstructive pulmonary disease (COPD), or people aged 18 or older who have been diagnosed with asthma or bronchiectasis.
People whose main reason for being admitted to hospital was a flare-up of COPD, asthma that was difficult to control, or a flare-up of bronchiectasis.

Who may not be able to join:

People who are unable to complete a breathing test (called spirometry) once their condition has settled.
People whose doctors expect them to survive less than one month.
People who choose not to sign the consent form agreeing to take part in the study.
People whose chest scans show certain types of abnormal findings, such as patches, solid areas, glassy-looking changes, or changes in the lung tissue, with or without fluid around the lungs.
People who have cystic fibrosis, interstitial lung disease, or other lung conditions that cause certain types of airway widening.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

China-Japan Friendship Hospital

Registry

ClinicalTrials.gov

Start date

1 February 2025

Est. completion

31 July 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Length of hospital stay

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov